BioWorld MedTech

Dec. 16, 2013

BioVentrix expands European trial of Revivent-TC via LIVE procedure

An implant intended to address the cause of heart failure that was once implanted during an open-chest procedure in the operating room is now being delivered via a less invasive technique in the catheter lab in a European clinical trial. Read More

Mindray moves upmarket with Zonare acquisition

International report: Echo grants rights to MTIA for Symphony CGM in China

Washington Roundup: Budget bill offers language for medical device tax repeal

Sundance will expand psychiatric evaluation

Grants: Ixico wins grant competition in UK for dementia products

Financings roundup: Xoma to sell common stock in public offering

Med-Tech Notes

People in Places

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 11, 2025.

FDA clears Dexcom G7 15 Day

BioWorld MedTech

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...